At the IGTP TODAY
On Thursday 29 February, the Germans Trias Hospital hosted the 'International Rare Disease Day Symposium'. Health professionals and researchers from the Hospital and IGTP discussed their work in advancing the field of rare diseases. Representatives from patient associations of these diseases also participated.
The European Union's project THRIVE held its kick-off meeting on 12 January 2024 in Barcelona. The project is coordinated by Josep M. Llovet (IDIBAPS). IGTP collaborates as a partner through c-LOG, led by Carolina Armengol.
In 2023, the IGTP has continued to make significant strides in its mission. Here, we review the year's top news stories, reflecting the persistent drive and collaborative spirit that underpin this institution.
Around 200 students from secondary schools in Badalona have visited different centres on the Can Ruti Campus this morning, taking part in one of the main events of the 28th edition of Science Week in Badalona. The Germans Trias i Pujol Research Institute (IGTP) has organised the event together with the Germans Trias Hospital.
The research, led by Cima Universidad de Navarra, sheds light on new possibilities for addressing various types of cancer. This work has been carried out in collaboration with Dr Carolina Armengol, leader of IGTP’s Childhood Liver Oncology (C-LOG) group, a pioneer in the study of childhood liver cancer in Spain.
A preclinical study with support from the Spanish Association Against Cancer has identified a potential treatment approach for patients with hepatoblastoma, which involves combining standard chemotherapy with a drug currently undergoing clinical trials. The research was conducted using patient samples and animal and laboratory models, and has been led by Dr Josep M. Llovet, professor at the UB and group leader at IDIBAPS, and Dr Carolina Armengol, group leader at IGTP and member of CIBEREHD.
To commemorate International Women's Day, we asked four questions to different profiles of IGTP researchers to find out about the difficulties they have encountered as women scientists and how they see the future: Dr Carolina Armengol, leader of the consolidated Childhood Liver Oncology Research Group (c-LOG), Dr Raquel Guillamat, junior leader of the emerging group Translational Research in Pulmonary Immunity, and PhD student Daina Martínez from the ICREC laboratory of Cardiology Research.
Encouraging news in the framework of the International Day Against Childhood Cancer. The Spanish Association Against Cancer, through its Aid Programmes, has granted 1.2 million euros to the coordinated project "Personalised Medicine for Childhood Liver Cancer". The five-year project will be coordinated by the Germans Trias i Pujol Research Institute (IGTP), under the leadership of Dr Carolina Armengol, with the participation of another four Spanish research groups. All participating groups are members of the CIBER of Hepatic and Digestive Diseases (CIBEREHD).
A collaborative CIBER project will boost hepatoblastoma (HB) research to identify new therapeutic targets that will allow strategies to be developed to improve the prognosis of those children who currently do not survive the disease. The project coordinated by Carolina Armengol, principal CIBEREHD researcher at the Germans Trias i Pujol Research Institute (IGTP) is a collaboration between 5 CIBER groups belonging to the Hepatic and Digestive Diseases area (CIBEREHD) and the Cancer area (CIBERONC).
CARE, the Translational Program in Cancer Research is the first transversal program promoted by the Germans Trias i Pujol Research Institute (IGTP), and it aims to become a bridge for researchers in the field of cancer who want to bring basic and clinical research together, so that the knowledge and the tools generated in the laboratory can benefit the patient.
